Meet and network with the key influencers shaping the law, policy and proceedings of Paragraph IV litigation.
Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.
As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.
Get judicial insights on the complex challenges facing both brand name and generic drug manufacturers:
United States Court of Appeals for the Federal Circuit

Honorable Kathleen M. O’Malley
United States Circuit Judge
United States Court of Appeals for the Federal Circuit
United States District Court
Honorable Stanley R. Chesler
United States District Judge
District of New Jersey
United States District Judge
District of New Jersey
Magistrate Judge
District of New Jersey
Honorable Mary Pat Thynge
Chief Magistrate Judge
District of Delaware
Magistrate Judge
District of Delaware
Chief Judge
Northern District of Illinois
Honorable Roy Payne
Magistrate Judge
Eastern District of Texas
United States Patent and Trademark Office, Patent Trial and Appeal Board
Honorable Jacqueline Wright Bonilla
Vice Chief, Administrative Patent Judge
Lead Administrative Patent Judge
Administrative Patent Judge
Hear from the FTC and the FDA on the latest antitrust and regulatory developments impacting Paragraph IV litigation
Markus H. Meier
Assistant Director, Health Care Division,
Bureau of Competition
Deputy Center Director for Regulatory Policy, CDER
Director, FDA Office of Generic Drug Policy, CDER
NEW for 2019!

Fireside chat with the
Hon. Kathleen M. O’Malley,
United States Circuit Judge

from Markus Meier, Assistant
Director of the Bureau of
Competition’s Health Care Division

HALL: Perspectives from the
Districts of NJ, Del, E.D Tex.

members of the FDA’s new
Hatch-Waxman Working Group

Insights from the District Court
and PTAB

Covering budgeting, trial
preparation, and international
concerns

Exciting New Breakout Tracks Covering Budgeting, Trial Preparation, and International Concern
- The Business of Pharmaceutical Patent Litigation
- The Practice of Pharmaceutical Patent Litigation: Part I
- ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s” (limited 20 attendees per session)
- A Town Hall with the Magistrate Judges (limited to 40 attendees per session)
- The Practice of Pharmaceutical Patent Litigation: Part II
- New Developments in Market Access and Exclusivities
Attend the conference that the “Who’s Who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice. Register now and be part of the prestigious meeting of the minds.
Event Contacts
For sponsorship opportunities please contact:
American Conference Institute
[email protected]
For media partnership opportunities please contact:
Linda Lam
Tel: 212-352-3220 ext. 5538
[email protected]
For questions about this year’s program/content, or information on how you can speak next year please contact:
Joseph Gallagher
Tel: 212.352.3220 ext. 5511
[email protected]